Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

12.11
+0.41003.50%
Post-market: 12.110.00000.00%17:30 EDT
Volume:139.23K
Turnover:1.66M
Market Cap:317.89M
PE:-8.26
High:12.50
Open:11.70
Low:11.22
Close:11.70
Loading ...

Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market!

TIPRANKS
·
29 Mar

Benitec Biopharma prices 1.44M shares at $13.00 in underwritten offering

TIPRANKS
·
26 Mar

Benitec Biopharma Prices $30 Million Equity Offerings

MT Newswires Live
·
25 Mar

Benitec Biopharma Inc - Prices Offering of 2,343,000 Shares

THOMSON REUTERS
·
25 Mar

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering

GlobeNewswire
·
25 Mar

Benitec Biopharma Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Mar

Promising Clinical Trial Results for Benitec Biopharma’s BB-301 Reinforce Buy Rating

TIPRANKS
·
24 Mar

Benitec Biopharma (BNTC) Receives a Buy from Piper Sandler

TIPRANKS
·
20 Mar

Benitec Biopharma Announces Positive Interim Results for BB-301

TIPRANKS
·
19 Mar

Benitec Biopharma reports interim results for 3 subjects treated with BB-301

TIPRANKS
·
19 Mar

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated With Bb-301 in Phase 1B/2a Study to Be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

THOMSON REUTERS
·
19 Mar

Benitec Biopharma Price Target Maintained With a $18.00/Share by Citizens Capital Markets

Dow Jones
·
18 Mar

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
10 Mar

Benitec Biopharma to Participate in Upcoming Conferences in March

GlobeNewswire
·
26 Feb

Benitec Biopharma Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Feb

Analysts Are Bullish on These Healthcare Stocks: Benitec Biopharma (BNTC), Halozyme (HALO)

TIPRANKS
·
19 Feb

Benitec Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Feb

BRIEF-Benitec Biopharma Releases Second Quarter 2025 Financial Results

Reuters
·
14 Feb

Benitec Biopharma Inc expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
14 Feb

Benitec Biopharma Q2 2025 GAAP EPS $(0.33) Beats $(0.87) Estimate

Benzinga
·
14 Feb